These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9802524)

  • 1. Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism.
    Schluger JH; Ho A; Borg L; Porter M; Maniar S; Gunduz M; Perret G; King A; Kreek MJ
    Alcohol Clin Exp Res; 1998 Oct; 22(7):1430-6. PubMed ID: 9802524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of the hypothalamic-pituitary-adrenal axis with the opioid antagonist nalmefene.
    Geer EB; Landman RE; Wardlaw SL; Conwell IM; Freda PU
    Pituitary; 2005; 8(2):115-22. PubMed ID: 16379031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects.
    Wand GS; Weerts EM; Kuwabara H; Wong DF; Xu X; McCaul ME
    Addict Biol; 2013 Jan; 18(1):181-92. PubMed ID: 22264217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys.
    Williams KL; Ko MC; Rice KC; Woods JH
    Psychoneuroendocrinology; 2003 May; 28(4):513-28. PubMed ID: 12689609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?
    Kiefer F; Jahn H; Otte C; Naber D; Wiedemann K
    Biol Psychiatry; 2006 Jul; 60(1):74-6. PubMed ID: 16483549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism.
    King AC; Schluger J; Gunduz M; Borg L; Perret G; Ho A; Kreek MJ
    Neuropsychopharmacology; 2002 Jun; 26(6):778-88. PubMed ID: 12007748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of body mass on the hypothalamic-pituitary-adrenal-axis response to naloxone in patients with polycystic ovary syndrome.
    Guido M; Ciampelli M; Fulghesu AM; Pavone V; Barini A; de Marinis L; Cento R; Caruso A; Lanzone A
    Fertil Steril; 1999 Mar; 71(3):462-7. PubMed ID: 10065783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome.
    Scott LV; Burnett F; Medbak S; Dinan TG
    Psychol Med; 1998 Mar; 28(2):285-93. PubMed ID: 9572086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine effects of naltrexone versus nalmefene in humans.
    Butelman ER; Fry RS; Kimani R; Reed B; Kreek MJ
    Hum Psychopharmacol; 2020 Mar; 35(2):e2726. PubMed ID: 32050055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.
    Lanzone A; Guido M; Ciampelli M; Fulghesu AM; Pavone V; Proto C; Caruso A; Mancuso S
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):73-7. PubMed ID: 8796141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
    Hockings GI; Grice JE; Crosbie GV; Walters MM; Jackson AJ; Jackson RV
    J Clin Endocrinol Metab; 1993 Aug; 77(2):404-8. PubMed ID: 8393884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute HPA axis response to naltrexone differs in female vs. male smokers.
    Roche DJ; Childs E; Epstein AM; King AC
    Psychoneuroendocrinology; 2010 May; 35(4):596-606. PubMed ID: 19837518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic-pituitary-adrenal axis in abdominal obesity: effects of dexfenfluramine.
    Boushaki FZ; Rasio E; Serri O
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):461-6. PubMed ID: 9196609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
    O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic-pituitary-adrenal axis response to oral naltrexone in alcoholics during early withdrawal.
    Besirli A; Eşel E; Özsoy S; Turan T
    Pharmacopsychiatry; 2014 Jul; 47(4-5):151-5. PubMed ID: 24936803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of CRH, Dexamethasone and Naltrexone on the Mu, Delta and Kappa Opioid Receptor Agonist Binding in Lamb Hypothalamic-Pituitary-Adrenal Axis.
    Pierzchała-Koziec K; Dziedzicka-Wasylewska M; Oeltgen P; Zubel-Łojek J; Latacz A; Ocłon E
    Folia Biol (Krakow); 2015; 63(3):187-93. PubMed ID: 26462331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable dose naltrexone-induced hypothalamic-pituitary-adrenal stimulation in abstinent alcoholics: a preliminary study.
    Farren CK; O'Malley S; Grebski G; Maniar S; Porter M; Kreek MJ
    Alcohol Clin Exp Res; 1999 Mar; 23(3):502-8. PubMed ID: 10195825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between the stimulated hypothalamic-pituitary-adrenal axis and leptin in humans.
    Nye EJ; Bornstein SR; Grice JE; Tauchnitz R; Hockings GI; Strakosch CR; Jackson RV; Torpy DJ
    J Neuroendocrinol; 2000 Feb; 12(2):141-5. PubMed ID: 10718909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.